IMCD consensus paints a clear picture, analysts see upside for the shares
22.06.2026 - 18:44:29 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 18:40.
IMCD (NL0010801007) trades on Euronext Amsterdam with a clearly positive analyst backdrop. Fresh consensus data show a Buy stance with a marked spread between the current share price and average 12-month targets.
What the consensus shows today
According to the latest overview on Investing.com, 14 analysts currently cover IMCD, with 10 recommending Buy, 3 Hold and 1 Sell. The same consensus lists an average 12-month price target of 112.00 euros, with the most bullish estimate at 150 euros and the lowest at 75 euros. This implies an upside potential of roughly 36 percent versus the platform’s referenced last price level.
The consensus snapshot also underlines that IMCD is viewed as a structurally growing specialty chemicals distributor, an area where listed peers such as Brenntag in Germany and Azelis in Belgium are also active. For retail investors, the analyst distribution provides a benchmark against these European sector peers, both of which are represented in indices like the DAX and Stoxx Europe 600.
How IMCD compares with peers
In the specialty chemicals distribution space, Brenntag on Xetra and Azelis on Euronext Brussels serve as useful reference points for valuation and growth. IMCD’s consensus upside of around 36 percent sits in the upper range of typical analyst gaps for established European mid caps, indicating that research houses still see room for fundamental growth. Market commentators highlight that distributors like IMCD benefit from diversified supplier bases and exposure to end markets such as pharmaceuticals, food and industrial applications, which can smooth demand over the cycle.
Background and data on the IMCD shares
All articles, company reports and price information on IMCD in one place help investors track both analyst views and fundamentals over time.
How IMCD earns its money
IMCD generates its revenue by distributing specialty chemicals and ingredients, acting as an intermediary between chemical producers and industrial customers in sectors such as pharmaceuticals, food, personal care and coatings. The group typically offers formulation support and technical advice in addition to pure distribution, which can help deepen customer relationships and support margins over time.
Where the stock trades now
The IMCD shares (NL0010801007) most recently traded on Euronext Amsterdam at around 82 euros, with this indicative level based on the consensus reference price as of the latest Investing.com update on IMCD.
Key data on the IMCD shares
- Company: IMCD N.V.
- ISIN: NL0010801007
- WKN: A110V2
- Ticker: IMCD
- Trading venue: Euronext Amsterdam
- Price (as of latest Investing.com consensus update): approx. 82 EUR
- Market cap: not live-verified in this snapshot
- Sector / industry: Chemicals - Specialty distribution
- Index membership: not live-verified in this snapshot
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, an offer or a solicitation to buy or sell any securities. Historical data and analyst assessments are no guarantee of future performance.
